B.O'Mahony^1,2; J.Mahlangu³; K.Peerlink⁴; JDWang⁵; G.Lowe⁶; CWTan⁷; A.Giermasz⁸; H. Tran⁹; TLKhoo¹⁰; E. Cockrell¹¹; D.Pepperell¹²; H.Chambost¹³; MFLFernández¹⁴; R.Kazmi¹⁵; E.Majerus¹⁶; MWSkinner^17,18; R.Klamroth¹⁹; J.Quinn²⁰; H.Yu²⁰; WYWong²⁰; A.Lawal²⁰; TMRobinson²⁰; B.Kim²⁰

¹Persatuan Haemofilia Ireland;²Kolej Trinity, Dublin, Ireland;³ Pusat Penjagaan Komprehensif Hemofilia, Hospital Akademik Charlotte Maxeke Johannesburg, Universiti Witwatersrand dan NHLS, Johannesburg, Afrika Selatan;⁴ Jabatan Perubatan Vaskular dan Pusat Haemostasis dan Haemophilia, Hospital Universiti Leuven, Leuven, Belgium;⁵ Pusat Penyakit Jarang dan Hemofilia, Hospital Besar Veteran Taichung, Taichung, Taiwan, Wilayah China;⁶ Pusat Haemofilia Penjagaan Komprehensif West Midlands, Hospital Queen Elizabeth, Birmingham, United Kingdom;⁷ Jabatan Hematologi, Hospital Diraja Adelaide, Adelaide, Australia;⁸ Pusat Rawatan Hemofilia, Universiti California Davis, Sacramento, Amerika Syarikat;⁹ Unit Haemostasis & Trombosis, Pusat Rawatan Haemofilia, The Alfred Hospital, Melbourne;¹⁰ Institut Hematologi, Hospital Putera Diraja Alfred, Camperdown, Australia;¹¹ Onkologi Hematologi Pediatrik, Hospital Kanak-Kanak Saint Joseph, Tampa, Amerika Syarikat;¹² Jabatan Hematologi, Hospital Fiona Stanley, Murdoch, Australia;¹³ AP-HM, Jabatan Onkologi Hematologi Pediatrik, Hospital Kanak-kanak La Timone, Universiti Aix Marseille, INSERM, INRA, C2VN, Marseille, Perancis;¹⁴ Complejo Hospitalario Universitario A Coruña, A Coruña, Sepanyol;¹⁵ Jabatan Hematologi, Hospital Universiti Southampton, Southampton, United Kingdom;¹⁶ Jabatan Perubatan, Universiti Washington di St. Louis, St. Louis;¹⁷ Institute for Policy Advancement Ltd, Washington, Amerika Syarikat;¹⁸ Universiti McMaster, Hamilton, Kanada;¹⁹ Pusat Rawatan Haemofilia Penjagaan Komprehensif, Vivantes Klinikumim Friedrichshain, Berlin, Jerman;²⁰ BioMarin Pharmaceutical Inc., Novato, Amerika Syarikat